181 related articles for article (PubMed ID: 38474456)
1. Chemotherapeutic Activities of New η
Ywaya DO; Ibrahim H; Friedrich HB; Bala MD; Soobramoney L; Daniels A; Singh M
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474456
[TBL] [Abstract][Full Text] [Related]
2. Antimalarial activity of ruthenium(II) and osmium(II) arene complexes with mono- and bidentate chloroquine analogue ligands.
Ekengard E; Glans L; Cassells I; Fogeron T; Govender P; Stringer T; Chellan P; Lisensky GC; Hersh WH; Doverbratt I; Lidin S; de Kock C; Smith PJ; Smith GS; Nordlander E
Dalton Trans; 2015 Nov; 44(44):19314-29. PubMed ID: 26491831
[TBL] [Abstract][Full Text] [Related]
3. Potent and selective anticancer activity of half-sandwich ruthenium and osmium complexes with modified curcuminoid ligands.
Pagliaricci N; Pettinari R; Marchetti F; Pettinari C; Cappellacci L; Tombesi A; Cuccioloni M; Hadiji M; Dyson PJ
Dalton Trans; 2022 Sep; 51(35):13311-13321. PubMed ID: 35983757
[TBL] [Abstract][Full Text] [Related]
4. Effect of
Mukherjee A; Acharya S; Purkait K; Chakraborty K; Bhattacharjee A; Mukherjee A
Inorg Chem; 2020 May; 59(9):6581-6594. PubMed ID: 32295347
[TBL] [Abstract][Full Text] [Related]
5. Chloro half-sandwich osmium(II) complexes: influence of chelated N,N-ligands on hydrolysis, guanine binding, and cytotoxicity.
Peacock AF; Habtemariam A; Moggach SA; Prescimone A; Parsons S; Sadler PJ
Inorg Chem; 2007 May; 46(10):4049-59. PubMed ID: 17441712
[TBL] [Abstract][Full Text] [Related]
6. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of Ru(II) piano-stool complexes with chloroquine and chelating ligands against breast and lung tumor cells: Interactions with DNA and BSA.
Colina-Vegas L; Villarreal W; Navarro M; de Oliveira CR; Graminha AE; Maia PIDS; Deflon VM; Ferreira AG; Cominetti MR; Batista AA
J Inorg Biochem; 2015 Dec; 153():150-161. PubMed ID: 26277415
[TBL] [Abstract][Full Text] [Related]
8. Organometallic Ru(II), Rh(III) and Re(I) complexes of sterane-based bidentate ligands: synthesis, solution speciation, interaction with biomolecules and anticancer activity.
Pivarcsik T; Kiss MA; Rapuš U; Kljun J; Spengler G; Frank É; Turel I; Enyedy ÉA
Dalton Trans; 2024 Mar; 53(11):4984-5000. PubMed ID: 38406993
[TBL] [Abstract][Full Text] [Related]
9. Half-sandwich Ru(η
Huang YC; Haribabu J; Chien CM; Sabapathi G; Chou CK; Karvembu R; Venuvanalingam P; Ching WM; Tsai ML; Hsu SCN
J Inorg Biochem; 2019 May; 194():74-84. PubMed ID: 30831392
[TBL] [Abstract][Full Text] [Related]
10. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.
Peacock AF; Habtemariam A; Fernández R; Walland V; Fabbiani FP; Parsons S; Aird RE; Jodrell DI; Sadler PJ
J Am Chem Soc; 2006 Feb; 128(5):1739-48. PubMed ID: 16448150
[TBL] [Abstract][Full Text] [Related]
11. Solution equilibrium, structural and cytotoxicity studies on Ru(η
Dömötör O; Kiss MA; Gál GT; May NV; Spengler G; Nové M; Gašparović AČ; Frank É; Enyedy ÉA
J Inorg Biochem; 2020 Jan; 202():110883. PubMed ID: 31689626
[TBL] [Abstract][Full Text] [Related]
12. Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms.
Hildebrandt J; Häfner N; Kritsch D; Görls H; Dürst M; Runnebaum IB; Weigand W
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563367
[TBL] [Abstract][Full Text] [Related]
13. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.
Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ
Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447
[TBL] [Abstract][Full Text] [Related]
14. Anticancer Properties of Ru and Os Half-Sandwich Complexes of N,S Bidentate Schiff Base Ligands Derived from Phenylthiocarbamide.
Arshad JZ; Tabassum S; Kiani MS; Arshad S; Hashmi MA; Majeed I; Ali H; Shah SSA
Chem Asian J; 2023 Dec; 18(23):e202300804. PubMed ID: 37737043
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization, antimicrobial and cytotoxic activity of novel half-sandwich Ru(II) arene complexes with benzoylthiourea derivatives.
Obradović D; Nikolić S; Milenković I; Milenković M; Jovanović P; Savić V; Roller A; Đorđić Crnogorac M; Stanojković T; Grgurić-Šipka S
J Inorg Biochem; 2020 Sep; 210():111164. PubMed ID: 32634653
[TBL] [Abstract][Full Text] [Related]
16. DNA binding, antitubercular, antibacterial and anticancer studies of newly designed piano-stool ruthenium(II) complexes.
Navale G; Singh S; Agrawal S; Ghosh C; Roy Choudhury A; Roy P; Sarkar D; Ghosh K
Dalton Trans; 2022 Nov; 51(42):16371-16382. PubMed ID: 36250384
[TBL] [Abstract][Full Text] [Related]
17. Thiourea-Derived Chelating Ligands and Their Organometallic Compounds: Investigations into Their Anticancer Activity.
Tong KKH; Hanif M; Lovett JH; Hummitzsch K; Harris HH; Söhnel T; Jamieson SMF; Hartinger CG
Molecules; 2020 Aug; 25(16):. PubMed ID: 32796732
[TBL] [Abstract][Full Text] [Related]
18. Ruthenium(II) and osmium(II) 1,2,3-triazolylidene organometallics: a preliminary investigation into the biological activity of 'click' carbene complexes.
Kilpin KJ; Crot S; Riedel T; Kitchen JA; Dyson PJ
Dalton Trans; 2014 Jan; 43(3):1443-8. PubMed ID: 24201979
[TBL] [Abstract][Full Text] [Related]
19. Tuning the cytotoxic properties of new ruthenium(III) and ruthenium(II) complexes with a modified bis(arylimino)pyridine Schiff base ligand using bidentate pyridine-based ligands.
Garza-Ortiz A; Maheswari PU; Lutz M; Siegler MA; Reedijk J
J Biol Inorg Chem; 2014 Jun; 19(4-5):675-89. PubMed ID: 24430199
[TBL] [Abstract][Full Text] [Related]
20. Reactive Oxygen Species Production Is Responsible for Antineoplastic Activity of Osmium, Ruthenium, Iridium and Rhodium Half-Sandwich Type Complexes with Bidentate Glycosyl Heterocyclic Ligands in Various Cancer Cell Models.
Kacsir I; Sipos A; Bényei A; Janka E; Buglyó P; Somsák L; Bai P; Bokor É
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]